| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gorman Kevin Charles is a Director at NEUROCRINE BIOSCIENCES INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $82.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 2, 2017 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 21,739 | $53.23 | $1,157,166.97 | -6.1% | |
| Apr 12, 2017 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 19,596 | $50.42 | $988,085.28 | -2.9% | |
| Feb 6, 2017 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sale+OE | 3,010 | $43.18 | $129,971.80 | -1.2% | |
| Feb 3, 2017 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 3,125 | $42.55 | $132,968.75 | -1.2% | |
| Jan 17, 2017 | NBIX Neurocrine Biosciences Inc | Chief Executive Officer | Sell | 3,750 | $40.65 | $152,437.50 | -1.5% |